Views & Analysis Measuring the cost of diabetes Can patient education programmes start reducing the burden?
Views & Analysis The 'game changers' in diabetes: Novo and Lilly battle it ou... Two diabetes drugs, Lilly and Boehringer Ingelheim’s (BI) Jardiance and Novo Nordisk’s Victoza, have shown they can go beyond lowering blood sugar, and actually save lives and cut heart attacks
Views & Analysis Digital health round-up: a new dawn in diabetes care, and mo... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis The first ever ‘artificial pancreas’ is here - the iPhone of... Medtronic's hybrid closed loop device is the first step towards a true 'artificial pancreas'
News J&J's long-lasting diabetes combo approved in US Company looks to new drugs as US Remicade competition looms.
News Roche, Viking, and Syntis showcase obesity drug candidates A flurry of clinical readouts for new weight-loss therapies has seen Roche, Viking, and Syntis all showing off new drug candidates.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
